PACB.NASDAQPacific Biosciences of California, INC

Form 4: PACB Officer Sells Shares for Tax Obligations

Sentiment:

Insider Transaction Report

📋All filings for Pacific Biosciences of California, INC
🔒Login to Follow

Michele Farmer, Chief Accounting Officer of Pacific Biosciences, sold 2,979 shares of common stock to cover tax withholding obligations.

Summary

  • Michele Farmer, Chief Accounting Officer of Pacific Biosciences of California, Inc. (PACB), reported a transaction on March 3, 2026.
  • Farmer sold 2,979 shares of PACB common stock at a weighted average price of $1.514 per share.
  • The sale was mandatory and conducted to cover tax withholding obligations related to the vesting of restricted stock units.
  • Following this transaction, Farmer directly beneficially owns 305,948 shares of PACB common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale is non-discretionary and solely for tax purposes, not indicative of management's view on the company's future prospects.

Industry Context

StockSavvy.ai notes that routine insider sales for tax withholding purposes are common across all industries, particularly for executives receiving equity compensation. This transaction is specific to the individual's compensation structure rather than a reflection of broader industry trends or company performance.

Stakeholder Impact

  • Shareholders: Minimal direct impact as the sale is small and for tax purposes, not a discretionary divestment.
  • Employees: No direct impact mentioned.
  • Customers: No direct impact mentioned.
  • Suppliers: No direct impact mentioned.
  • Creditors: No direct impact mentioned.

Key Dates

DateDescription
03/03/2026Date of earliest transaction (sale of common stock).
03/04/2026Signature date of the reporting person.

Recommendation

hold

This Form 4 filing reports a routine, non-discretionary sale of shares by an officer to cover tax obligations related to equity compensation. Such transactions are common and do not typically signal a change in the company's fundamentals or management's confidence. Therefore, it provides no new information to warrant a change in investment thesis, suggesting a 'hold' recommendation for existing positions.

Keywords

Pacific Biosciences, PACB, Form 4, Insider Trading, Stock Sale, Michele Farmer, Chief Accounting Officer, Tax Withholding, Restricted Stock Units

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.